M&A Deal Summary |
|
|---|---|
| Date | 2024-08-28 |
| Target | Bowen Therapeutics |
| Sector | Life Science |
| Buyer(s) | UTime |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Electronics |
| Employees | 99 |
| Revenue | 251M CNY (2025) |
UTime provides mobile devices to consumers globally and helps low-income individuals from established markets, including the United States, and emerging markets, such as India and countries in South Asia and Africa, have better access to updated mobile technology. The company currently transforms health and wellness through innovative medical wearable technologies. UTime was formed in 2008 and is based in Shenzhen, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
